Oruka Therapeutics to Present at Multiple November Investor Conferences

Rhea-AI Summary

Oruka Therapeutics (Nasdaq: ORKA), a biotech company focused on developing novel biologics for chronic skin diseases including plaque psoriasis, has announced its participation in two major investor conferences in November 2024. The company will present at the Stifel 2024 Healthcare Conference on November 18th at 2:25PM ET and the Jefferies London Healthcare Conference on November 20th at 2:00PM GMT. Webcasts and replays of the presentations will be accessible through Oruka's investor events website.

News Market Reaction – ORKA

-0.88%

1 alert

-0.88% News Effect

On the day this news was published, ORKA declined 0.88%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MENLO PARK, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced presentations at the following upcoming investor conferences:

Stifel 2024 Healthcare Conference
Date: Monday, November 18^th, 2024
Time: 2:25PM ET

Jefferies London Healthcare Conference
Date: Wednesday, November 20^th, 2024
Time: 2:00PM GMT

A webcast and replay of Oruka’s presentation will be available on the Oruka investor events website at https://ir.orukatx.com/news-events/events-presentations.

About Oruka Therapeutics

Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com and follow Oruka on LinkedIn.

Investor Contact: 
Alan Lada 
(650)-606-7911 
alan.lada@orukatx.com 

FAQ

When is Oruka Therapeutics (ORKA) presenting at the Stifel Healthcare Conference in 2024?

Oruka Therapeutics (ORKA) is presenting at the Stifel Healthcare Conference on Monday, November 18th, 2024, at 2:25PM ET.

What time is Oruka Therapeutics (ORKA) presenting at the Jefferies London Healthcare Conference in 2024?

Oruka Therapeutics (ORKA) is presenting at the Jefferies London Healthcare Conference on Wednesday, November 20th, 2024, at 2:00PM GMT.

Where can investors watch Oruka Therapeutics' (ORKA) November 2024 conference presentations?

Investors can watch the webcasts and replays of Oruka's presentations on the company's investor events website at https://ir.orukatx.com/news-events/events-presentations.

What therapeutic areas does Oruka Therapeutics (ORKA) focus on?

Oruka Therapeutics focuses on developing novel biologics for the treatment of chronic skin diseases, including plaque psoriasis.